K Number
K102520
Device Name
BD NEXIVA CLOSED IV CATHETER SYSTEM
Date Cleared
2011-01-06

(126 days)

Product Code
Regulation Number
880.5200
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
As indicated in 21 CFR Part 880.5200, The Nexiva™ intravascular catheter is inserted into a patient's vascular system for a short-term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravascularly. The needle-shielding feature and luer access port, aid in the prevention of needle-stick injuries. Blood is contained within the device during the catheter insertion process aiding in the prevention of blood exposure. This catheter may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of procedure. The 18-22 gauge Nexiva™ catheters are suitable for use with power injectors rated for a maximum of 300 psi when the luer access port(s) is removed and a direct connection is made.
Device Description
The BD Nexiva™ Closed IV Catheter System consists of an over-the needle, peripheral intravascular catheter made from Vialon™ polyurethane, integrated extension tubing with a Y adapter and clamp, BD Q-Syte™ luer access port, and a passive needleshielding mechanism. The design of the Nexiva™ IV catheter can be described as a closed system since it protects clinicians from blood exposure during the catheter insertion procedure. Since the needle is withdrawn through a septum that seals after the needle has been removed and both ports of the Y adapter are closed, blood is contained within the NexivaTM device during catheter insertion. The pressure exerted on the needle as it passes through the septum wipes blood from the needle, further reducing potential blood exposure. The slide clamp on the integrated extension tubing is provided to eliminate blood exposure when the vent plug is replaced with an infusion set connection of a BD Q-Syte™ luer access port.
More Information

Not Found

No
The summary describes a mechanical medical device (intravascular catheter) and its physical features for safety and performance. There is no mention of software, algorithms, or data processing that would indicate the use of AI or ML. The performance studies focus on material biocompatibility and manufacturing quality metrics (DPPM, Cpk).

No.
The device is used for basic medical procedures like sampling blood, monitoring blood pressure, or administering fluids, which are supportive functions and not inherently therapeutic. Its primary features relate to safety and convenience (e.g., needle-shielding, blood containment) rather than direct treatment of a disease or condition.

No

The device is an IV catheter used for administering fluids, monitoring blood pressure, and sampling blood, not for diagnosing a medical condition.

No

The device description clearly outlines physical components made of materials like Vialon™ polyurethane, integrated extension tubing, a Y adapter, a clamp, a luer access port, and a passive needleshielding mechanism. This indicates a hardware-based medical device, not a software-only one.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states the device is for insertion into a patient's vascular system for purposes like sampling blood, monitoring blood pressure, or administering fluids. These are direct interactions with the patient's body, not tests performed in vitro (outside the body) on samples.
  • Device Description: The description focuses on the physical components and how they function within the patient's vascular system (catheter, tubing, ports, needle-shielding). It describes a "closed system" for containing blood during insertion, not for analyzing blood samples.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples, detecting specific analytes, or providing diagnostic information based on laboratory testing. The performance metrics (DPPM, Cpk) relate to manufacturing quality and physical performance, not diagnostic accuracy.

In summary, the BD Nexiva™ Closed IV Catheter System is a medical device used for accessing the vascular system for therapeutic and monitoring purposes, not for performing diagnostic tests on biological samples.

N/A

Intended Use / Indications for Use

The Nexiva™ intravascular catheter is inserted into a patient's vascular system for a short-term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravascularly. The needle-shielding feature and luer access port, aid in the prevention of needle-stick injuries. Blood is contained within the device during the catheter insertion process aiding in the prevention of blood exposure. This catheter may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of procedure.

The 18-22 gauge Nexiva™ catheters are suitable for use with power injectors rated for a maximum of 300 psi when the luer access port(s) is removed and a direct connection is made.

Product codes

FOZ

Device Description

The BD Nexiva™ Closed IV Catheter System consists of an over-the needle, peripheral intravascular catheter made from Vialon™ polyurethane, integrated extension tubing with a Y adapter and clamp, BD Q-Syte™ luer access port, and a passive needleshielding mechanism.

The design of the Nexiva™ IV catheter can be described as a closed system since it protects clinicians from blood exposure during the catheter insertion procedure. Since the needle is withdrawn through a septum that seals after the needle has been removed and both ports of the Y adapter are closed, blood is contained within the NexivaTM device during catheter insertion. The pressure exerted on the needle as it passes through the septum wipes blood from the needle, further reducing potential blood exposure. The slide clamp on the integrated extension tubing is provided to eliminate blood exposure when the vent plug is replaced with an infusion set connection of a BD Q-Syte™ luer access port.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

patient's vascular system

Indicated Patient Age Range

any patient population

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Nonclinical Tests:
Product Performance Characteristics/Verification Testing and Acceptance Criteria:

  1. Premature Decouple Force: DPPM

§ 880.5200 Intravascular catheter.

(a)
Identification. An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.(b)
Classification. Class II (performance standards).

0

Becton Dickinson Infusion Therapy Systems, Inc. 9450 South State Street Sandy UT 84070 tel: 801-565-2662 fax: 801-565-2749 iustice alder@hd.com

K102520/S2

Helping all people

live healthy lives

SPECIAL PREMARKET NOTIFICATION [510(K)] Summary- BD NexivaTM Closed IV Catheter System

Submitter:

Becton Dickinson Infusion Therapy Systems, Inc.

Address:

9450 South State Street Sandy, UT 84070

Contact Person:

Trade Names:

Common Name:

Classification Name:

Justice Alder Specialist, Regulatory Affairs

Telephone Number: Fax Number:

801-565-2749

801-565-2662

August 30, 2010

Date Summary Prepared:

BD Nexiva™ Closed IV Catheter System

Intravascular Catheter

Intravascular Catheter (FOZ) 880.5200

Unmodified/Predicate Device: (K032843) BD NexivaTM Closed IV Catheter System

Description of the device:

The BD Nexiva™ Closed IV Catheter System consists of an over-the needle, peripheral intravascular catheter made from Vialon™ polyurethane, integrated extension tubing with a Y adapter and clamp, BD Q-Syte™ luer access port, and a passive needleshielding mechanism.

The design of the Nexiva™ IV catheter can be described as a closed system since it protects clinicians from blood exposure during the catheter insertion procedure. Since the needle is withdrawn through a septum that seals after the needle has been removed and both ports of the Y adapter are closed, blood is contained within the NexivaTM device during catheter insertion. The pressure exerted on the needle as it passes through the septum wipes blood from the needle, further reducing potential blood exposure. The slide clamp on the integrated extension tubing is provided to eliminate blood exposure when the vent plug is replaced with an infusion set connection of a BD Q-Syte™ luer access port.

1

Intended Use of the BD Nexiva™ Closed IV Catheter System device: [21 CFR Part 880—GENERAL HOSPITAL AND PERSONAL USE DEVICES; General Hospital and Personal Use Therapeutic Devices Sec. 880.5200]

The Nexiva™ intravascular catheter is inserted into a patient's vascular system for a short-term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravascularly. The needle-shielding feature and luer access port, aid in the prevention of needle-stick injuries. Blood is contained within the device during the catheter insertion process aiding in the prevention of blood exposure. This catheter may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of procedure.

The 18-22 gauge Nexiva™ catheters are suitable for use with power injectors rated for a maximum of 300 psi when the luer access port(s) is removed and a direct connection is made.

Technological Characteristics Comparison:

The BD NexivaTM Closed IV Catheter products have the same technological characteristics with no changes in intended use. The subject device has similar design features and materials as the predicate device. The table below shows the design features and material comparisons between the predicate and subject device.

Subject DevicePredicate Device
1. Catheter adapter,
tip shieldCatheter Adapter -
Decreased adapter pocket
width to 0.075" for tighter
control of adapter retention
lock mechanism
Tip Shield -Decrease V-clip
pocket opening to 0.077" for
tighter control of V-clip
movement when engaged
with adapter
Tip Shield -Scaling of Internal
ID through holes to cannula
gauge to improve control of
cannula to tip shield
movementCatheter Adapter -Adapter
pocket width set at 0.088"
Tip Shield -V-clip pocket
width set at 0.084"
Tip Shield -Internal ID holes
were generalized to
accommodate all cannula
gauge sizes
2. Catheter material.Catheter material -VialonCatheter material - Vialon
Catheter adapterX40, Radio opaque material
Catheter Adapter-24Ga ID
set to 0.0406" decreased by
0.0004"X50, Radio opaque material
Catheter Adapter -24Ga ID
0.0410"
3. Catheter adapter,
needle coverCatheter Adapter -needle
cover modified to remove
bumps, have a straight
interference fit and a solid
stop feature
Needle Cover -Length set to
2.26" (0.040" shortened)Catheter Adapter -needle
cover interface had 2 bump
interference features and a
tapered nose
Needle Cover -Length was
2.30"
4. Extension tubingExt. Tubing -increased
diameters for 18,20 Ga
productExt. Tubing -all gauges
microbore tubing
5. ClampClamp -pinch clampClamp -slide clamp
6. Catheter adapter, Luer
adapterCatheter Adapter -tubing
junction increased ID for
macrobore tubing,
optimized for adhesive
addition)
Luer Adapter -tubing
junction increased ID for
macrobore tubing,
optimized for adhesive
addition)Catheter Adapter -
designed for microbore
tubing and solvent bond
joint
Luer Adapter -tubing
junction defined with a
swedge design
7. Leur adapterLuer Adapter -PCTG "Y"
adapter
8. Catheter adapterCatheter Adapter -smaller
adapter wing structure
(confined within overmolded
soft wing)Catheter Adapter -large
adapter wing structure
(confined within overmolded
soft wing)
9. Tip shieldTip Shield -improved
ergonomic gripping side wall
design to prevent user
applying force to catheter
adapter directlyTip Shield -Straight side wall
design
10. PackagingPackage -Rigid designPackage -Blister package of
constrained unit package
(dispenser, shipper scaled to
new unit package)assembly
11. Straight luer adapterStraight Luer Adapter -
added new configurationStraight Luer Adapter -did
not exist
12. Vent plugVent Plug -placed in straight
adapter for air ventingVent Plug -placed on "Y"
adapter for air venting
13. Q-Syte, Q-Syte Dust
Cover, and End CapQ-Syte, Q-Syte Dust Cover
and End Cap -removed for
straight configurationQ-Syte, Q-Syte Dust Cover
and End Cap -placed on "Y"
configuration
14. CannulaCannula -bump indented into
cannula for tip shield retentionCannula -ferrule bound to
cannula for tip shield retention
15. Retaining featureRetaining Feature -washer
retains cannula "bump" to
prevent tip shield removalRetaining Feature -retention
plate retains cannula ferrule to
prevent tip shield removal
16. V-ClipV-Clip -flag for cannula tip
barrierV-Clip -no cannula tip barrier
(barrier provided by retention
plate)
17. Cannula, CatheterCannula -ID, OD gauge size
increase as ferrule removed
Catheter -tip resized to
cannula gauge increaseCannula -smaller gauge size
to accommodate cannula
ferrule
Catheter -tip confirms to
cannula gauge size
18. WedgeWedge -Improved reduced ID
wedge design as ferrule was
removed from cannulaWedge -larger ID wedge to
accommodate cannula ferrule
19. Tip shieldTip Shield -internal ID holes
scaled to smaller cannula sizeTip Shield -internal ID
increased for larger cannula
size
20. GripGrip -internal ID increased for
larger cannula sizeGrip -internal ID holes scaled
to smaller cannula size

2

·

.

3

4

Nonclinical Tests Support Substantial Equivalence:

The BD Nexiva™ Closed IV Catheter System is composed of material that have been tested in accordance with ANSI/AAMI/ISO 10993-1 2003 (E) standards. The design verification activities, acceptance criterion, and results have been summarized below which demonstrates safety and efficacy of the device.

.

| Associated
Modification | Product Performance Characteristics/Verification Testing | Acceptance Criteria for
Product Verification |
|----------------------------|-----------------------------------------------------------|-------------------------------------------------|
| 1 | Premature Decouple Force | DPPM